We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
30 Jan 2023 - 02 Feb 2023

AI-Based Biomarker Uses CT Scans to Predict Immunotherapy Response for Lung Cancer Patients

By MedImaging International staff writers
Posted on 06 Jan 2023
Print article
Image: New AI-based biomarker can help predict immunotherapy response for patients with lung cancer (Photo courtesy of Emory University)
Image: New AI-based biomarker can help predict immunotherapy response for patients with lung cancer (Photo courtesy of Emory University)

Immunotherapy is often the first line of treatment for patients with non-small cell lung cancer, which represents 84% of all lung cancers, according to the American Cancer Society. However, most patients don’t achieve durable results from immune checkpoint inhibitor (ICI) therapies, a type of immunotherapy. In a retrospective study, researchers have now discovered a new artificial intelligence (AI)-derived biomarker that uses routine imaging scans to help predict which patients with lung cancer will respond to immunotherapy. The findings not only offer guidance for patients and their physicians making treatment decisions, but can also curtail the financial burden associated with immunotherapy.

The new biomarker, quantitative vessel tortuosity (QVT), was discovered by a team of researchers from several health care systems and universities, including Emory University (Atlanta, GA, USA), and can influence tumor behavior and therapeutic resistance. Tumors appropriate the body’s machinery for building new blood vessels and redirect as much blood as possible to the tumors so they can grow faster and spread throughout the body. Compared to normal blood vessels, tumor-associated vasculature is chaotically arranged and twisted.

The researchers used AI tools to evaluate different aspects of QVT biomarkers in more than 500 cases of patients with non-small cell lung cancer before and after they were treated with ICI therapies. The researchers discovered that the tumor vasculature of patients who do not respond to ICI therapies is more twisted compared to those who do respond. They hypothesize that blood vessel twistedness causes antitumor cells to accumulate at the tumor site but fail to efficiently infiltrate the tumor, diminishing the effectiveness of immunotherapy. In future work, the researchers will seek to validate QVT biomarkers in prospective clinical trials.

“Immunotherapy only tends to benefit approximately 30% of patients. With the high expense of treatments and a 70% failure rate, we have to find better ways to predict and monitor responses to therapy,” says Anant Madabhushi, PhD, study author and professor in the Wallace H. Coulter Department of Biomedical Engineering at Emory University School of Medicine and Georgia Institute of Technology College of Engineering, and member of the Cancer Immunology research program at Winship Cancer Institute of Emory University. “When making decisions on who to treat and how to treat them, clinicians really need interpretable features. Vessel tortuosity is a novel radiomics method that uses an interpretable and intuitive AI approach to evaluate whether the tumor is responding to therapy even before more obvious changes like tumor size become apparent.”

Related Links:
Emory University

Gold Supplier
Ultrasound Transducer/Probe Cleaner
Transeptic Cleaning Solution
Fixed X-Ray System
PerfoX 3000 Eco
New
Ultrasound Probe Covers
Intuit
New
SPECT System
AnyScan S

Print article
CIRS -  MIRION

Channels

Radiography

view channel
Researchers used AI to triage patients with chest pain (Photo courtesy of Pexels)

First Deep Learning AI Model Triages Patients with Chest Pain Using X-Rays

Acute chest pain syndrome can involve tightness, burning or other discomfort in the chest or a severe pain that spreads to the back, neck, shoulders, arms, or jaw, accompanied by shortness of breath.... Read more

Ultrasound

view channel
Image: Dr. Derek Cool demonstrating the new robotic 3D ultrasound system (Photo courtesy of Lawson Health)

Robotic 3D Ultrasound System Improves Accuracy of Liver Cancer Treatment

Liver cancer is the fourth-leading cause of cancer death in the world. Surgery is one treatment option for liver cancer, although thermal ablation which uses heat to destroy the cancerous tumor has less... Read more

Nuclear Medicine

view channel
Image: Tracking radiation treatment in real time promises safer, more effective cancer therapy (Photo courtesy of Pexels)

Real-Time 3D Imaging Provides First-of-Its-Kind View of X-Rays Hitting Inside Body During Radiation Therapy

Radiation is used in treatment for hundreds of thousands of cancer patients each year, bombarding an area of the body with high energy waves and particles, usually X-rays. The radiation can kill cancer... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.